-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...
More »SEARCH RESULT
Kerala tackles prejudice and prices -C Maya
-The Hindu The State population stands at a little over three crore, but average consumption of drugs is three times the national average In Kerala, where people have a marked preference for branded drugs, where the most expensive brand is considered the best, and only those brands pushed by doctors sell, the new Drug (Prices Control) Order, which is expected to cut prices by 20-25 per cent, may not have much of...
More »Smoking bans, taxes can save 9 million Indians: study
-PTI India could prevent over nine million deaths due to cardiovascular disease over the next decade if it implements smoking bans and levy higher tobacco taxes, a new study has found. Smoke-free laws and increased tobacco taxes would yield substantial and rapid health benefits by averting future cardiovascular disease (CVD) deaths, researchers said. "Smoke-free legislation has not been consistently implemented, one in three adults reported being exposed to smoking at work in 2009...
More »Blood pressure drugs and antibiotics to be cheaper as government plans to notify price caps -Soma Das
-The Economic Times NEW DELHI: Top-selling blood pressure drugs and antibiotics could become a lot cheaper as the government plans to notify price caps for 51 essential drugs early next week under a new drug price control order that was enforced last month. Under this second lot of notifications by the National Pharma Pricing Authority, the brands selling the most expensive antibiotics would have to cut their prices by 30-60%. For instance, the...
More »Who Manufactures Dirty Medicines?-Amit Sengupta
-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...
More »